Other

Net Change in Cash Excluding FX Effect

Kailera Therapeutics Net Change in Cash Excluding FX Effect increased by 33.3% to -$48.44M in Q1 2026 compared to the prior quarter.

Analysis

StatementCash Flow Statement
SectionOther
First reportedQ1 2025
Last reportedQ1 2026May 26, 2026
Metric ID: hd_net_change_in_cash_ex_fx

Historical Data

2 periods
 Q1 '25Q1 '26
Value-$72.64M-$48.44M
QoQ Change—+33.3%
YoY Change—+33.3%
Range-$72.64M – -$48.44M
Avg YoY Growth+33.3%
Median YoY Growth+33.3%

Frequently Asked Questions

What is Kailera Therapeutics 's net change in cash excluding fx effect?
Kailera Therapeutics (KLRA) reported net change in cash excluding fx effect of -$48.44M in Q1 2026.